- €2.21m
- €2.04m
- €0.70m
- 88
- 37
- 52
- 63
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.28 | 0.312 | 0.375 | 0.638 | 0.697 |
Cost of Revenue | |||||
Gross Profit | 0.233 | 0.277 | 0.316 | 0.412 | 0.51 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 0.165 | 0.202 | 0.261 | 0.722 | 0.543 |
Operating Profit | 0.115 | 0.11 | 0.113 | -0.084 | 0.154 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 0.104 | 0.098 | 0.103 | -0.093 | 0.143 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.102 | 0.093 | 0.06 | -0.101 | 0.124 |
Net Income Before Extraordinary Items | |||||
Net Income | 0.102 | 0.093 | 0.06 | -0.101 | 0.124 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.102 | 0.093 | 0.06 | -0.101 | 0.124 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.119 | 0.108 | 0.07 | -0.118 | 0.145 |
Dividends per Share |